Screening for Substance Use Disorders/Opioid Use Disorder

Identify patients with or at risk for opioid use disorders or other substance use disorders across a variety of settings and patient populations.

Screening Protocol for Perinatal Mood and Anxiety Disorders for Primary Care Providers

This guide will explans how to choose a screening tool for Perinatal Mood and Anxiety Disorders (PMADs), provides recommendations and resources on how to administer the tools, recommends additional screening tools, presents an algorithm and response protocol, and briefly touches on establishing outside resources and referrals.

MCPAP for Moms

MCPAP for Moms provides obstetricians, midwives, and PCPs with psychiatric consultation for behavioral health concerns and questions around medications when pregnant or breastfeeding. MCPAP for Moms also supports connections with community-based services and support groups.

Vital Signs: Drug Overdose Deaths, by Selected Sociodemographic and Social Determinants of Health Characteristics — 25 States and the District of Columbia, 2019-2020

This report describes changes in drug overdose death rates from 2019 to 2020, stratified by sex, age group, and race and ethnicity. In addition, it examines differences in circumstances surrounding drug overdose, and assesses differences in overdose death rates by county-level income inequality and availability of mental health treatment providers and providers of medications for opioid use disorder.